drugset / Trial / NCT06236113
Low Dose Ketamine for Blunt Thoracic Trauma
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The goal of this Randomized controlled double-blinded trial is to compare the addition of a ketamine infusion to placebo, when added to standard care in adult blunt trauma patients with multiple rib fractures. The main question it aims to answer are: • addition of low dose ketamine infusion (LDKI) decreases narcotic use • does LDKI impact pulmonary complications, readmission, or hospital length of stay Participants will receive usual standard of care with up to 48 hours of LDKI or placebo. If there is a comparison group: Researchers will compare infusion of a saline infusion to LDKI to see if LDKI decreases need for narcotic analgesics use.
Timeline
- Start
- 2021-10-01
- Primary completion
- 2023-03-19
- Completion
- 2023-06-26
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ketamine | Small molecule | 0.1 mg/kg | Intravenous |
Indications
No indication recorded.